HealthDay Now: Trials Show COVID Vaccines Well Worth It for Cancer Patients

As the European Society for Medical Oncology (ESMO) concluded its annual meeting, HealthDay's Mabel Jong spoke to Dr. Antonio Passaro, a member of the ESMO council and a medical oncologist at the European Institute of Oncology in Milan. Dr. Passaro shared the highlights from this year's conference and discussed research supporting the need to vaccinate cancer patients against COVID-19.

Related Stories

No stories found.
logo
www.healthday.com